FTSE 100 p harma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...

Stock markets have tumbled as shocked investors react to the “Liberation Day” tariffs unveiled by President Trump at the ...

President Trump imposed a 10% baseline levy on all exporters to the U.S., and higher tariffs on several dozen nations, ...

Donald Trump imposed 10 per cent 'reciprocal' tariffs on the UK last night - but hit the rest of the world even harder as he ...

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

Nigeria has struggled with raw material dependency, exporting raw materials while importing finished products at exorbitant costs, which has stifled industrialisation and weakened the real sector ...

Kinaxis and NSF AI4OPT at Georgia Tech expand their partnership to transform academic innovation into real-world supply chain ...

Challenges and opportunities evolve over time, and we stay ahead of them through our continuous applied research initiatives ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Pharma stocks just got a new risk factorand it's not a new drug trial. President Trump is preparing to slap tariffs on ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.